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REGULATION OF GUT COMMENSAL FLORA ATTENUATES OSTEOARTHRITIS
THROUGH INTERLEUKIN 17
Dongsheng Yu, Jun Dai, Hongwei Ouyang, Li Dak Sum, Yip Yio Chin
Center for Stem Cell and Regenerative Medicine, Zhejiang University School of
Medicine, China
Objective: To examine the role of interleukin 17 (IL-17) in cartilage destruction
during the progression of osteoarthritis (OA), and determine whether regulation
of gut commensal flora can attenuate osteoarthritis through IL-17.
Methods: OA and normal synovium from mice and human were subjected to
immunohistochemistry (IHC) of IL-17 expression. Experimental osteoarthritis
was created by destabilization of the medial meniscus (DMM) surgery in MINK1
knock out mice and different conditioned or vancomycin-treated C57BL/6
mice. OA development, gut flora and IL-17 expression were evaluated using
SO staining, 16sRNA sequence, SEM, IHC and flow cytometry. Primary cultured
mouse chondrocytes were treated with recombinant IL-17.
Results: We found that there is an OA subgroup with enhanced IL-17 expression
in synovium. IL-17 increased activities of MMP13 and decreased matrix synthesis
in chondrocytes. Intra-articular injection of IL-17 accelerated articular cartilage
degradation and high IL-17 expression in MINK1 knock-out mice also accelerated
OA development. Interestingly, C57BL/6 mice obtained from different microbial
conditions displayed difference in IL-17 expression and OA progress. Subsequent
16sRNA sequence analysis demonstrated different composition of gut microbe,
including one special bacteria called SFB in the Firmicutes. Regulation of gut
microflora by antibiotic attenuated osteoarthritis progress in DMM mice and
this alleviation was reversed after colonization of non-SPF mouse fecal
microflora.
Conclusion: Gut microbe is involved in OA pathology by modulating proinflamma-
tory cytokine IL-17 activity. Regulation of gut microflora maybe a potential therapy
in a high IL-17 expression subgroup of OA patients.
http://dx.doi.org/10.1016/j.jot.2016.06.185Session: Regenerative Medicine e Tissue Engineering
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DIRECTING TENOGENESIS OF STEM CELLS WITH SMALL MOLECULE-BASED
NANOFIBERS
Can Zhang, Erchen Zhang, Xiao Chen, Hongwei Ouyang, Li Dak Sum, Yip Yio Chin
Center for Stem Cells and Regenerative Medicine School of Medicine, Zhejiang
University, China
Objective: Epigenetic studies on stem cells have indicated that specific histone al-
terations and DNA methylation play essential roles in cell differentiation. Different
from chemical cue, topographical cue is often used to guide cells to orientate,
which is also important in tissue development. Here, we examined the effect of
small molecule modified scaffolds to direct tendon progenitor/stem cells (TSPCs)
differentiate into tendons in vitro and in vivo.
Methods: The histone deacetylation inhibitor TSA were combined on the aligned
nanofibers. TSPCs obtained from Scx-GFP mouse were seeded onto the aligned
and TSA modified aligned nanofibers. The gene expression of tendon related genes
were examined. Confocal observation was further performed. A rat Achilles
tendon defect model was created and implanted with aligned or TSA modified
aligned scaffold in vivo. The morphology of repaired tissues were analyzed by his-
tological examination and transmission electron microscope. The amount of depos-
ited collagen was quantified using a collagen quantitative assay kit. Mechanical
testing was performed for mechanical properties.
Results: TSA could release from the scaffold for 24h. Gene expression profile
showed that TSA modified align group upregulated the tendon related genes
compared to the align group. Scx-GFP as a report system also showed that TSPCs
cultured on the TSA-A (i.e. TSA modified aligned scaffold) scaffold maintain
strong GFP fluorescence and cells exhibited spindle-shaped morphology, in
contrast to weak GFP fluorescence on A (i.e. TSA modified aligned scaffold) scaf-
fold. In rat Achilles tendon repair model, TSA-A treated tendon had superior
structural and mechanical properties than A-treated tendon. These findings pre-
sent a strategy combining well-aligned fiber scaffold with small molecule for
tendon regeneration and may assist in clinical regenerative medicine to treat
tendon diseases.
Conclusion: TSA modified scaffold promotes tendon regeneration by changing the
epigenetic and promoting tendon related genes expression both in vitro and in
vivo.
http://dx.doi.org/10.1016/j.jot.2016.06.186Session: Disease & Treatment e Osteoporosis
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PREVENTIVE EFFECTS OF POLYGONUM MULTIFLORUM ON GLUCOCORTICOID-
INDUCED OSTEOPOROSIS IN MALE RATS
Jingkai Wu a,b, Jin Li a,b, Yongjie Yu a,b, Manru Zhou a,b, Weimin Yao a,c,
Yajun Yang a,b, Yuyu Liu a,b
aDepartment of Pharmacology, Guangdong Medical University, China
bGuangdong Key Laboratory for Research and Development of Natural Drugs,
Guangdong Medical University, Zhanjiang, Guangdong 524023, China
cAffiliated Hospital of Guangdong Medical University, China
Objective: To investigate the effects of PM on glucocorticoid-induced lumbar
spine and femur microstructure in male rats.
Methods: The crude extract of the PM was extracted by 75% ethanol, 30% ethanol
extract of the PM was purified and enriched by the D-101 macro-resin column from
the crude extracts, and then determined by HPLC. Male Sprague-Dawley rats
(190e230 g, nZ180) were randomly divided into eighteen cages, which for nine
groups: control, prednisone, prednisone plus calcitriol (CAL), prednisone plus
30% ethanol extract of the PM (H, M, L) dose, prednisone plus crude extract of
the PM (H, M, L) dose. Prednisone was administrated orally for 21 weeks in the
male rat model of osteoporosis. Meanwhile, PM and extracts mentioned above
were administrated in male rats exposed to prednisone. The right femur and fourth
LV were collected for the measurement of three-dimensional microarchitecture of
micro-CT analysis, detect bone microstructure and bone mineral density, and other
related parameters
Results: The content of 2, 3, 5, 40-tetrahydroxystilbene-2-O-b-glucoside (TSG)
and combined anthraquinone (CAQ) were 9.20% and 0.15% in the sample of
30% ethanol extract of the PM, and 2.23% and 0.03% in the sample of crude
extract of the PM, respectively. Male rats exposed to prednisone exhibited the
deteriorated microarchitecture, low BMD, decreased BV/TV. While 30% ethanol
extract of the PM (M, L) and crude extract of the PM (H) counteracted the alter-
ations of skeletal characteristics induced by prednisone in male rats, as well as
CAL.
Conclusions: 30% ethanol extract of the PM (M, L) and crude extract of the PM (H)
dose groups can exert a protective influence on bone tissue in GIO male rats.
http://dx.doi.org/10.1016/j.jot.2016.06.187Session: Disease & Treatment e Cartilage Damage & Repair
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SMALL MOLECULE KARTOGENIN PROMOTES CARTILAGE REGENERATION
THROUGH ACTIVATING IL-6-BASED MESENCHYMAL STEM CELL PROLIFERATION
Guangqian Zhou, Xiaolin Li, Tao Liu, Tuanhui Chen, Jun Li, Yuhong Liang
The Centre for Anti-ageing and Regenerative Medicine of Shenzhen University,
China
Introduction: Deregulation of the endogenous stem cells in cartilage tissues is
considered to be a part of pathogenesis of osteoarthritis. Kartogenin (KGN) has
been reported to exert stimulatory effects on chondrogenesis of mesenchymal
stem cells by binding to filamin A that subsequently releases and activates tran-
scription factor CBFb and by up-regulate the Smad2/3 phosphosphorylation. In
this study, we report that KGN is capable of stimulating the proliferation of pri-
mary cartilage derived progenitor cells (CPCs).
Subjects and Methods: Cartilage derived progenitor cells (CPC) were isolated
from rat articular cartilage tissues and KGN stimulated-CPC proliferation was
confirmed both in vitro and in vivo. Slow-cycling cells within cartilage were
labeled and counted using RrdU and it specific antibodies. Cell cycle was
analyzed using Flow Cytometry and RNA-seq was performed on CPC co-incu-
bated with KGN for 5 days. IL-6 and Stat3 phosporylation were detected with
ELISA kit and Western blotting. Cartilage repair/regeneration by oral adminis-
tration and/or intra-articular injection of KGN was observed in rat knee joint
injury models.
Results: Our data shows that following 10 mM KGN treatment for a week, the
percentage of G2-M phase cells in mitosis reached 9.6%, nearly twice of the
control group, which was companied with the doubled total cell number. In
the meanwhile, even after 4 weeks stimulation with KGN, Cells were proved
to remain the expression of mesenchymal stem cell markers CD90 (93%) and
CD105 (98%). As a control, no significant number change was observed in mature
human T lymphocyte treated with KGN in the similar manner. Whole RNA-
sequencing analysis of KGN-stimulated MSCs showed that significant expression
changes of about 20 cell cycle-related genes upon KGN treatment for 72 hours.
Among a number of genes found to be significantly changed by the KGN treat-
ment are IL-6 and its receptor Gp130, which reach as much as 6 fold increase
134 Poster Presentation Abstractsthan the control. We further confirmed that the IL-6 level was significantly
increased by KGN in both cytoplasm and supernatant media of CPC culture.
We further demonstrated that the phosphosphorylation of Stat-3 was up-
regulated at the same time. In-articular injection of KGN were also found to
increase the number of BrdU-labeled slow-cycling cells. In vivo experimental
evidences of the increased thickness in articular cartilage with KGN treatment
was further confirmed in the rat model that were induced to have knee joint
injury. IHC staining of the KGN treatment group showed up-regulate of Stat-3
phosphosphorylation in KGN-treated cartilage.
Discussion and Conclusions: Based on the in vivo and in vitro data, we propose
that KGN may improve the number of endogenous cartilage stem cells by promot-
ing their self-renewal in situ while inducing chondrogenesis and its use in cartilage
regeneration and repair is definitely worth of further explored.
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Sox9 SUPPRESSES THE HYPERTROPHY OF CHONDROCYTES BY INHIBITING
wnt/b-CATENIN SIGNALING PATHWAY
Kun Chen, Peng Cheng, Min Zhou, Yuting Wang, Anmin Chen
Tongji Hospital, Tongii Medical College, Huazhong University of Science and
Technology, China
Background: Due to its low cell density and low proliferative activity, and its avas-
cular character, articular cartilage is virtually unable to regenerate or self-heal
upon injury or degeneration by common diseases such as osteoarthritis. Scientists
have tried many ways to inhibit the degeneration of chondrocytes or repair the
cartilage defect. However, there is still no effective solutions to these problems.
Sox9 has been reported as an important transcription factor during the develop-
ment of cartilage. We have thought to overexpress Sox9 to see its role in
chondrocytes.
Subjects and Methods: The lentivirus vector was constructed to overexpress the
Sox9 in the chondrocytes. And the plasmids contain the full Sox9 and DC, DN
Sxo9 were constructed. These lentivirus and plasmids were transfected to the
articular chondrocytes of SD rats. Then western-blot, immunofluorescence, and
Alician blue staining were done to test the change of chondrocytes in order to
find the role of Sox9 in the chondrocytes.
Results: When chondrocytes were transfected with lentivirus to overexpress Sox9,
Western-blot showed that the expression of COL2a was upregulated and the
expression of COL10 and RUNX2 was downregulated. Meanwhile, the b-catenin
and p-GSK-3b were downregulated and the p-b-catenin and GSK-3b were upregu-
lated. And these changes can be relieved when Gsk inhibitor Licl and SB were
used. The Alician blue staining showed that when used wnt/b-catenin activator
Wnt3A to treat chondrocytes was weaker than the control group and the Sox9 over-
expression group was stronger than the control group. These results indicate that
the overexpression of Sox9 in chondrocytes can suppress the expression of RUNX2
and COL10 in chondrocytes and suppress the hypertrophy of chondrocytes. And
Sox9 acts through inhibiting wnt/b-catenin signaling pathway by activating the
GSK–3b. Furthermore, when chondrocytes were transfected with plasmids of
Sox9, DC and DN Sxo9, the Western-blot showed that in Sox9, DC Sox9 and DN
Sxo9 groups, b-catenin COL10 and RUNX2 were downregulated, while p-b-catenin,
GSK-3b and COL2a were upregulated. And the DC group was changed more signif-
icantly than the DN Sox9 group. These results suggest that the DC part of Sox9 may
play the main role in the function of Sox9 in chondrocytes.
Discussion and Conclusion: According to the results, Sox9 can suppress the hyper-
trophy of chondrocytes. And it acts through inhibiting the phosphorylation of GSK-
3b, and then inhibit the wnt/b-catenin signaling pathway. This makes Sox9 a prom-
ising way to treat the hypertrophy of chondrocytes.
http://dx.doi.org/10.1016/j.jot.2016.06.189Session: Regenerative Medicine e Stem Cells & Progenitors
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STUDY ON THE EFFECT OF PKC-z IN SDF-1a/CXCR4 AXIS INDUCED MIGRATION
OF RAT BONE MARROW MESENCHYMAL STEM CELLS
Hui Liu, Yonghui Dong, Peng Cheng, Kun Chen, Anmin Chen, Hui Huang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology, China
Background: Bone mesenchymal stem cells (BMSCs) are bone marrow-derived cells
with multipotent differentiation capability that can differentiate into osteoblasts,
adipocytes and chondrocytes. BMSCs have generated a lot of interest because oftheir potential use in regenerative medicine and tissue engineering. A great deal
of studies have shown that the SDF-1a is critical for mesenchymal stem cells migra-
tion to injured tissue through interaction with its cognate CXCR4 on the surface of
these cells. However, migration signaling pathways required for homing and
recruitment of BMSCs are not fully understood. Due to the known effects of
PKC-z on the migration of cancers and CD34+ progenitor cells, we have sought to
investigate the relationship between PKC-z and SDF-1a/CXCR4 axis induced migra-
tion of BMSCs.
Subjects and Methods: The rat BMSCs were cultured by using the whole bone
marrow adherence method. The three-line differentiations of BMSCs was conduct-
ed and cell surface markers were identified by flow cytometry. Transwell migration
assay was used to observe the migrating number of BMSCs that were treated with
AMD3100 and PS-z in response to SDF-1a. Western blot analysis was used to analyze
the phosphorylation of PKC-z of BMSCs upon SDF-1a and PS-z stimulation. Actin-
Tracker Green was applied to illustrate morphology of cell cytoskeleton by staining
of the F-actin. Laser scanning confocal microscopy was used to observe the polar-
ization of BMSCs after SDF-1a stimulation.
Results: The BMSCs that were cultured in vitro had the potential of multiple differ-
entiation into osteoblasts or adipocytes and highly expressed CD29 and CD90
except CD45.The migrating number of BMSCs increased gradually with the increase
of SDF-1a concentration in vitro, and the amount of BMSCs in the filter membrane
was approximately maximum when SDF-1a was 100ng/mL, but AMD3100 and PS-z
were able to cut down the number of BMSCs in the filter membrane. SDF-1a
increased the level of phosphorylation of PKC-z, while PS-z inhibited the phosphor-
ylation of PKC-z. Laser confocal microscopy confirmed that the cytoskeleton of
BMSCs treated with SDF-1a changes significantly, but AMD3100 and PS-z inhibited
this effects.
Discussion and Conclusion: Our result suggests that SDF-1a induces the migration
of BMSCs via affecting the phosphorylation of signaling protein PKC-z and changing
the cytoskeleton of BMSCs. This may increase the number of transplanted BMSCs
migration to injured tissue and organ to promote the rehabilitation.
http://dx.doi.org/10.1016/j.jot.2016.06.190Session: Others
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Notch1-ANTAGONISTIC APTAMER FOR CHONDROGENIC DIFFERENTIATION OF
BONE MARROW STROMAL CELLS
Se-Young Jeong, Mi-Lan Kang, Ji-Eun Kim, Gun-Il Im
Dongguk University Ilsan Hospital, South Korea
Introduction: Aptamers are oligonucleotide or peptide molecules that bind to a
specific target molecule such as small molecules, proteins, nucleic acids, and
even cells, tissues and organisms. Aptamers exhibit significant advantages relative
to protein therapeutics in terms of size, synthetic accessibility and modification by
medicinal chemistry. During murine skeletal development, Notch-1 is strongly
localized within the condensing mesenchyme during the early stages of chondro-
genesis [1]. Notch signaling is implicated in the repression of chondrogenic differ-
entiation of mesenchymal stem cell (MSC) [2]. The purpose of this study was to
investigate the possibility of Notch1-antagonistic aptamer as nucleic acid thera-
peutics to induce chondrogenic differentiation of human bone marrow stromal
cells (hBMSCs).
Methods: 1) Cytotoxicity test. hBMSCs (1104 cells/well on 96 well plate) were
treated with three Notch1 aptamer clone candidates from 1 to 1000 nM for 7
days. On day 1, 4 and 7, MTT assay was performed. 2) Validation of Notch1-antag-
onistic aptamer to select Notch1-antagonistic aptamer, expression of Notch1
downstream target genes including Hes and Hey were investigated by RT-qPCR
on hBMSCs treated with each of Notch1 aptamer candidate in DMEM/F12. 3) Median
effective dose (ED50). Pellets of hBMSCs (2.5105 cells, passage 3e5) were
cultured in DMEM/F-12 supplemented with dexamethasone (10e7 M), BSA (7.5%
w/v), L-proline (50 mM), ascorbate-2-phosphate (50 mM), sodium pyruvate (1 mM)
and ITS (1% v/v) containing different concentration of Notch1 aptamer (1, 10,
100 and 1000 nM). 4) In vitro chondrogenic differentiation. The hBMSCs
(2.5105 cells, passage 3e5) were made by pellets and were cultured in chondro-
genic medium containing Notch1-antagoistic aptamer (200 nM) from day 0 to 14. 5)
Gene expression profiling with oligonucleotide microarrays. Expression profiling
was performed by Illumina Expression Beadchip Analysis Service using Illumina
HumanHT-12 v4 Expression BeadChip (Illumina, Inc., San Diego, CA, USA). Hierar-
chical clustering was performed complete linkage algorithm using GeneSpring GX
7.3.1 software (Agilent, Santa Clara, CA, USA).
Results: 1) Cytotoxicity test. The MTT data after exposure to the Notch1-antago-
nistic aptamer candidates from 1 to 1000 nM for 7 days showed no significant cyto-
toxicity. 2) Validation of Notch1-antagonistic aptamer. The gene expression of hes1
and hey1 significantly decreased in hBMSCs treated with Notch1-antagonistic
aptamer candidates for 7 days compared to those of untreated hBMSCs. 3) Median
effective dose. The gene expression of COL2, SOX9 and ACAN significantly
increased in hBMSCs treated with Notch1-antagonistic aptamer (100nM) for 14
days compared to those of untreated hBMSCs. 4) In vitro chondrogenic
